GTP binding protein 6 (GTPBP6), although less characterized than some of its GTPase relatives, is part of the larger family of GTP-binding proteins which play crucial roles in various cellular processes. These proteins are known for their ability to bind and hydrolyze guanosine triphosphate (GTP) to guanosine diphosphate (GDP), a reaction that is often coupled to conformational changes enabling them to act as molecular switches within the cell.The specific functions of GTPBP6 are not as well-defined as those of some other members of the GTPase family. However, it is believed to be involved in the regulation of ribosome biogenesis and possibly in RNA processing or modification. Ribosome biogenesis is a core cellular process involving the assembly of ribosomes, the cellular machines responsible for protein synthesis. GTPBP6 may influence this process by interacting with ribosomal RNA (rRNA) or with assembly factors in the nucleolus, where ribosome production occurs.
In general, GTP-binding proteins such as GTPBP6 are involved in signal transduction pathways, where they relay signals from outside the cell to the appropriate intracellular targets. These proteins can also play roles in cytoskeletal organization, vesicle trafficking, and the cell cycle.Mutations or dysregulation of GTPases can lead to a variety of diseases, from developmental disorders to cancer. As such, while the specific pathophysiological roles of GTPBP6 are yet to be fully elucidated, it is a protein of interest for further research. Understanding its function may provide insights into fundamental cellular mechanisms and reveal new opportunities for intervention in diseases where GTPase function is compromised.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi apparatus function and can influence GTPase-mediated processes, potentially affecting GTPBP6. | ||||||
Pifithrin-α hydrobromide | 63208-82-2 | sc-45050 sc-45050A | 5 mg 25 mg | $120.00 $300.00 | 36 | |
NSC23766 inhibits Rac1, a small GTPase, and could indirectly modulate GTPBP6 through altered GTPase activity. | ||||||
Erastin | 571203-78-6 | sc-205677 sc-205677A | 5 mg 50 mg | $372.00 $1614.00 | 1 | |
CID-1067700 is a general inhibitor of GTPases and could have indirect effects on GTPBP6. | ||||||
XL413 | 1169562-71-3 | sc-474909 | 5 mg | $275.00 | ||
ML141, a Cdc42 GTPase inhibitor, might indirectly affect GTPBP6 by modulating related GTPase activities. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin inhibits HMG-CoA reductase and can affect prenylation of GTPases, potentially influencing GTPBP6. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin, similar to Lovastatin, may impact GTPase prenylation and indirectly modulate GTPBP6. | ||||||
Mevastatin (Compactin) | 73573-88-3 | sc-200853 sc-200853A | 10 mg 50 mg | $77.00 $179.00 | 18 | |
Mevastatin, another HMG-CoA reductase inhibitor, could affect GTPase function and GTPBP6 indirectly. | ||||||
GGTI 298 | 1217457-86-7 | sc-361184 sc-361184A | 1 mg 5 mg | $193.00 $838.00 | 2 | |
GGTI-298 inhibits geranylgeranyltransferase, possibly affecting GTPBP6 by altering GTPase processing. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
Ribavirin, an antiviral drug, can have indirect effects on GTPases and possibly on GTPBP6. | ||||||
TNP 470 | 129298-91-5 | sc-296547 | 10 mg | $235.00 | ||
TNP-470 has been shown to affect various cellular processes, potentially including GTPase-related functions that could impact GTPBP6. | ||||||